Bahl & Gaynor Inc Merck & Co., Inc. Call Options Transaction History
Bahl & Gaynor Inc
- $19.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MRK
# of Institutions
3,826Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$25.2 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$12 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.66 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.97 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $256B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...